News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,678 Results
Type
Article (9895)
Company Profile (103)
Press Release (309680)
Multimedia
Podcasts (3)
Webinars (7)
Section
Business (107621)
Career Advice (637)
Deals (18683)
Drug Delivery (22)
Drug Development (36280)
Employer Resources (42)
FDA (5204)
Job Trends (6343)
News (167206)
Policy (10876)
Tag
2024 BioCapital Digital (5)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2025 Lone Star Bio Digital (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (583)
Accelerated approval (2)
Adcomms (8)
Allergies (25)
Alliances (23433)
ALS (40)
Alzheimer's disease (580)
Antibody-drug conjugate (ADC) (53)
Approvals (5235)
Artificial intelligence (79)
Autoimmune disease (11)
Automation (6)
Bankruptcy (128)
Best Places to Work (4981)
BIOSECURE Act (13)
Biosimilars (23)
Biotechnology (102)
Bladder cancer (39)
Brain cancer (13)
Breast cancer (116)
Cancer (1143)
Cardiovascular disease (38)
Career advice (556)
Career pathing (6)
CAR-T (79)
Cell therapy (233)
Cervical cancer (13)
Clinical research (29966)
Collaboration (370)
Compensation (241)
Complete response letters (5)
COVID-19 (711)
CRISPR (15)
C-suite (156)
Cystic fibrosis (42)
Data (1063)
Depression (12)
Diabetes (88)
Diagnostics (2576)
Digital health (4)
Diversity, equity & inclusion (15)
Drug discovery (53)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (28)
Earnings (46838)
Editorial (7)
Employer branding (6)
Employer resources (43)
Events (56519)
Executive appointments (450)
FDA (5689)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (354)
Gene editing (33)
Generative AI (6)
Gene therapy (112)
GLP-1 (219)
Government (798)
Guidances (23)
Healthcare (6311)
Huntington's disease (7)
IgA nephropathy (9)
Immunology and inflammation (39)
Indications (14)
Infectious disease (757)
Inflammatory bowel disease (71)
Inflation Reduction Act (3)
Influenza (19)
Intellectual property (46)
Interviews (68)
IPO (9471)
IRA (9)
Job creations (1614)
Job search strategy (513)
Kidney cancer (9)
Labor market (11)
Layoffs (135)
Leadership (5)
Legal (2817)
Liver cancer (43)
Lung cancer (168)
Lymphoma (73)
Management (13)
Manufacturing (120)
MASH (32)
Medical device (4171)
Medtech (4172)
Mergers & acquisitions (9539)
Metabolic disorders (227)
Multiple sclerosis (30)
NASH (6)
Neurodegenerative disease (28)
Neuropsychiatric disorders (5)
Neuroscience (836)
NextGen: Class of 2025 (2322)
Non-profit (976)
Northern California (1466)
Now hiring (6)
Obesity (109)
Opinion (66)
Ovarian cancer (47)
Pain (26)
Pancreatic cancer (37)
Parkinson's disease (121)
Partnered (8)
Patents (79)
Patient recruitment (52)
Peanut (15)
People (33660)
Pharmaceutical (14)
Pharmacy benefit managers (1)
Phase I (10443)
Phase II (13433)
Phase III (9184)
Pipeline (698)
Policy (33)
Postmarket research (796)
Preclinical (4111)
Press Release (72)
Prostate cancer (44)
Psychedelics (5)
Radiopharmaceuticals (147)
Rare diseases (131)
Real estate (2900)
Recruiting (17)
Regulatory (7977)
Reports (20)
Research institute (625)
Resumes & cover letters (88)
Rett syndrome (3)
RNA editing (1)
RSV (5)
Schizophrenia (33)
Series A (59)
Series B (43)
Service/supplier (2)
Sickle cell disease (17)
Southern California (1216)
Special edition (2)
Spinal muscular atrophy (67)
Sponsored (11)
Startups (1719)
State (1)
Stomach cancer (11)
Supply chain (23)
Tariffs (5)
The Weekly (2)
United States (11537)
Vaccines (143)
Venture capitalists (10)
Weight loss (49)
Women's health (7)
Worklife (2)
Date
Today (24)
Last 7 days (222)
Last 30 days (1294)
Last 365 days (17216)
2025 (4656)
2024 (18421)
2023 (20957)
2022 (27587)
2021 (28893)
2020 (25336)
2019 (18527)
2018 (14324)
2017 (14808)
2016 (13611)
2015 (16832)
2014 (13072)
2013 (10577)
2012 (11481)
2011 (12187)
2010 (11740)
Location
Africa (288)
Alabama (39)
Alaska (2)
Arizona (82)
Arkansas (3)
Asia (18735)
Australia (3233)
California (3224)
Canada (1075)
China (244)
Colorado (98)
Connecticut (131)
Delaware (62)
Europe (39360)
Florida (391)
Georgia (54)
Idaho (29)
Illinois (220)
India (11)
Indiana (143)
Iowa (2)
Japan (92)
Kansas (34)
Kentucky (11)
Louisiana (6)
Maine (44)
Maryland (401)
Massachusetts (2559)
Michigan (146)
Minnesota (193)
Mississippi (1)
Missouri (30)
Montana (16)
Nebraska (14)
Nevada (35)
New Hampshire (20)
New Jersey (836)
New Mexico (12)
New York (828)
North Carolina (521)
North Dakota (5)
Northern California (1466)
Ohio (87)
Oklahoma (7)
Oregon (7)
Pennsylvania (650)
Puerto Rico (4)
Rhode Island (15)
South America (435)
South Carolina (5)
Southern California (1216)
Tennessee (49)
Texas (389)
Utah (75)
Virginia (51)
Washington D.C. (22)
Washington State (394)
West Virginia (2)
Wisconsin (25)
319,678 Results for "pds biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences suggest history may not repeat itself.
March 19, 2025
·
8 min read
·
Ben Hargreaves
Press Releases
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 9, 2025
·
5 min read
Press Releases
PDS Biotech Leadership to Participate in March 2025 Conferences
March 12, 2025
·
5 min read
Press Releases
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
March 13, 2025
·
7 min read
Business
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell-activating platforms, today announced that the Company will provide a business update and release financial results for the year ended December 31, 2023, on Wednesday, March 27, 2024.
March 20, 2024
·
6 min read
Press Releases
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2024
December 9, 2024
·
5 min read
Press Releases
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
March 19, 2025
·
5 min read
Press Releases
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
March 28, 2025
·
10 min read
Press Releases
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
March 31, 2025
·
4 min read
Business
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a business update and reported financial results for the first quarter of 2024.
May 15, 2024
·
11 min read
1 of 31,968
Next
